PREP&
Live / Registered — Registered (as of 31 May 2022)
What this means for you
Registered since 31 May 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79317639
- Registration number
- 6741766
- Mark type
- Stylized text
- Filed
- 22 Apr 2021
- Published for opposition
- 15 Mar 2022
- Registered
- 31 May 2022
- Attorney of record
- Randolph E. Digges, III
Goods and services
- Class 001 — Chemicals: Chemical, biochemical and biotechnological diagnostic preparations used in science; non-medical reagents, enzymes and chemicals, used in analytical chemistry, for scientific and/or medical research use for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid isolation, amplification and analysis; chemical test kits for laboratory or research use for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, in particular comprising reagents, enzymes and buffer solutions for nucleic acid isolation, amplification and analysis
- Class 005 — Pharmaceuticals: Diagnostic preparations for medical and veterinary purposes, namely, diagnostics preparations for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely, nucleic acids; diagnostic reagents, enzymes and buffer solutions for nucleic acid isolation, amplification and analysis for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely, reagents, enzymes and buffer solutions for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely, nucleic acids; diagnostic kits containing preparations for medical and veterinary diagnostic purposes, namely, for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely, nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for nucleic acid isolation, amplification and analysis for medical or veterinary purposes
Owner
- Qiagen GmbH, DE
- Qiagen GmbH, DE
- Qiagen GmbH, DE
Prosecution history
- 07 Nov 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 16 Sept 2022 — GENERIC MADRID TRANSACTION SENT TO IB
- 16 Sept 2022 — GENERIC MADRID TRANSACTION CREATED
- 31 Aug 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 31 May 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 31 May 2022 — REGISTERED-PRINCIPAL REGISTER
- 15 Mar 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Mar 2022 — PUBLISHED FOR OPPOSITION
- 14 Mar 2022 — NOTIFICATION PROCESSED BY IB
- 23 Feb 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 23 Feb 2022 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 23 Feb 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Feb 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Feb 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Feb 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE